Evidence map›Paper›PMID 22439068›Full record

ArticleJournal of prenatal medicine2011

Hyperechogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome?

Maria Antonietta De Oronzo

Abstract read
In one paragraph

Article in Journal of prenatal medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Prenatal genetic testing for cystic fibrosis: a systematic review of clinical effectiveness and an ethics review.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Cystic Fibrosis.Pediatrics in review · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Echogenic bowel in the second trimester - Where to from here?Australasian journal of ultrasound in medicine · 2018
    Article
  11. Cystic fibrosis: a clinical view.Cellular and molecular life sciences : CMLS · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Maria Antonietta De OronzoOperative Unit of Gynecology, Campus Bio-Medico University, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

"Soft markers" are considered variants of normal and should be considered distinct from fetal anatomic malformations. Hyperechogenicity of the fetal bowel, is one of the few soft markers that can also associated with a variety of other pathologic conditions. In this review we will focalise our attention on the significate of an increased echogenicity of fetal bowel and on management of fetuses with this condition.

Indexed as

fetal softs markershyperechogenic fetal bowel.prenatal screeningultrasonography

Identifiers

PMID22439068
PMCPMC3279148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.